Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · Real-Time Price · USD
3.790
+0.140 (3.84%)
Feb 24, 2026, 4:00 PM EST - Market closed
Aurora Cannabis Revenue
Aurora Cannabis had revenue of 94.19M CAD in the quarter ending December 31, 2025, with 6.79% growth. This brings the company's revenue in the last twelve months to 373.12M, up 16.54% year-over-year. In the fiscal year ending March 31, 2025, Aurora Cannabis had annual revenue of 343.29M with 27.32% growth.
Revenue (ttm)
373.12M CAD
Revenue Growth
+16.54%
P/S Ratio
0.79
Revenue / Employee
347,733 CAD
Employees
1,073
Market Cap
215.22M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 343.29M | 73.66M | 27.32% |
| Mar 31, 2024 | 269.64M | 45.83M | 20.48% |
| Mar 31, 2023 | 223.80M | 2.47M | 1.11% |
| Jun 30, 2022 | 221.34M | -23.91M | -9.75% |
| Jun 30, 2021 | 245.25M | -23.45M | -8.73% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evolus | 285.82M |
| Akebia Therapeutics | 225.07M |
| Organigram Global | 204.21M |
| Lifecore Biomedical | 128.87M |
| Anika Therapeutics | 112.81M |
| Journey Medical | 59.40M |
| Alpha Teknova | 39.80M |
| BGM Group | 25.10M |
ACB News
- 6 days ago - Aurora Cannabis (ACB) Sees Notable Increase in Indicative Borrow Rate - GuruFocus
- 7 days ago - Aurora to Participate in the TD Cowen 46th Annual Health Care Conference - PRNewsWire
- 11 days ago - 3 Top Canadian Marijuana Stocks To Buy Sell Or Hold In 2026 - MarijuanaStocks
- 12 days ago - Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis - PRNewsWire
- 13 days ago - Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand - PRNewsWire
- 14 days ago - Aurora Cannabis Inc. 2026 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 19 days ago - Aurora Cannabis Reports Increased Revenue And Free Cash Flow For Q3-2026 - Seeking Alpha
- 20 days ago - Aurora Cannabis Inc (ACB) (Q3 2026) Earnings Call Highlights: Strategic Shifts and Global ... - GuruFocus